This guide identifies metabolic abnormalities in tumor lysis syndrome in malignancies, suggesting timely interventions to mitigate risks.
Tumor lysis syndrome (TLS) is a life-threatening oncologic emergency marked by severe metabolic abnormalities, including hyperuricemia, hyperkalemia, hyperphosphatemia, and hypocalcemia. Although commonly associated with hema.
No takes yet. Share an insight, caveat, or question.
Mathew et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: